Recent Posts
- Cycle Pharmaceuticals’ NITYR (nitisinone) tablets receives marketing authorization in Chile
- Longer shelf life for NITYR (nitisinone) tablets for HT-1 in the U.S. granted by the FDA
- Cycle Pharmaceuticals Receives Approval for Updated Infant Administration for NITYR (nitisinone) Tablets for HT-1 in U.S.
- Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S.
- Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs
Archives
- No comments have been published yet.
Find us on Facebook
Archives
Recent Posts
- Cycle Pharmaceuticals’ NITYR (nitisinone) tablets receives marketing authorization in Chile
- Longer shelf life for NITYR (nitisinone) tablets for HT-1 in the U.S. granted by the FDA
- Cycle Pharmaceuticals Receives Approval for Updated Infant Administration for NITYR (nitisinone) Tablets for HT-1 in U.S.
- Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S.
- Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs
Recent Tweets
-
@CRhodesDesign @123reg Hi Chris, please see this helpful video on how to delete and reinstall plugins >… twitter.com/i/web/status/1…
9 hours ago -
Wherever you are in the world, we hope that you have a blessed Friday & weekend. Need Avada support? >… twitter.com/i/web/status/1…
4 days ago -
@VadioGitazy Yep, the best is still to come :) <3 <3
7 days ago
Recent Comments